Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Omega-Class Glutathione Transferases of Carcinogenic Liver Fluke, Clonorchis sinensis, Modulate Apoptosis and Differentiation of Host Cholangiocytes. | Antioxidants (Basel) | 2021 | 34202740 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. | Cells | 2021 | 34202136 | PubTator, text mining | PubMed |
| Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways. | mSystems | 2021 | 34184910 | PubTator, text mining | PubMed |
| MYD88, NFKB1, and IL6 transcripts overexpression are associated with poor outcomes and short survival in neonatal sepsis. | Sci Rep | 2021 | 34183713 | PubTator, text mining | PubMed |
| Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway. | Cancer Cell Int | 2021 | 34183010 | PubTator, text mining | PubMed |
| p38β - MAPK11 and its role in female cancers. | J Ovarian Res | 2021 | 34174910 | PubTator, text mining | PubMed |
| p38-MAPK-mediated translation regulation during early blastocyst development is required for primitive endoderm differentiation in mice. | Commun Biol | 2021 | 34172827 | PubTator, text mining | PubMed |
| Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes. | Mol Oncol | 2021 | 34165921 | PubTator, text mining | PubMed |
| p38 MAPKs - roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets. | JCI Insight | 2021 | 34156029 | PubTator, text mining | PubMed |
| Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. | Adv Drug Deliv Rev | 2021 | 34139255 | PubTator, text mining | PubMed |
| MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer. | Front Genet | 2021 | 34127929 | PubTator, text mining | PubMed |
| In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis. | Sci Rep | 2021 | 34075069 | PubTator, text mining | PubMed |
| Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis. | Biomolecules | 2021 | 34067783 | PubTator, text mining | PubMed |
| Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. | Pharmaceuticals (Basel) | 2021 | 34065757 | PubTator, text mining | PubMed |
| Beiging Modulates Inflammatory Adipogenesis in Salt-Treated and MEK6-Transfected Adipocytes. | Cells | 2021 | 34064531 | PubTator, text mining | PubMed |
| NFAT5-Mediated Signalling Pathways in Viral Infection and Cardiovascular Dysfunction. | Int J Mol Sci | 2021 | 34064510 | PubTator, text mining | PubMed |
| Bone Cells Differentiation: How CFTR Mutations May Rule the Game of Stem Cells Commitment? | Front Cell Dev Biol | 2021 | 34026749 | PubTator, text mining | PubMed |
| Alleviation of acute pancreatitis-associated lung injury by inhibiting the p38 mitogen-activated protein kinase pathway in pulmonary microvascular endothelial cells. | World J Gastroenterol | 2021 | 34025070 | PubTator, text mining | PubMed |
| Autophagy-related signaling pathways are involved in cancer (Review). | Exp Ther Med | 2021 | 34007319 | PubTator, text mining | PubMed |
| Long intergenic non-coding RNA 00473 promotes proliferation and migration of gastric cancer via the miR-16-5p/CCND2 axis and by regulating AQP3. | Cell Death Dis | 2021 | 33993193 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=27